Impact of emerging clinical trends on overall cost of care and the role of the managed care pharmacist

Abstract

Managed care payers, pharmacy directors, pharmacy benefit managers, specialty pharmacy directors, and any other pharmacist and/or healthcare professional interested in scientific advances for combination therapies in the treatment of metastatic triple-negative breast cancer. Accreditation StatementPharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity number 0290-0000-21-127-H01-P. The activity is available for CE credit through October 15, 2021.Obtaining Credit: Participants must read the article and complete the online posttest and an online evaluation and request for credit. Detailed instructions on obtaining CE credit are included at the end of this activity.